DRMA Earnings

Quarterly EPS
$-41.82
Q2 2024
$-20.41
Q3 2024
$21.86
Q4 2024
$-4.47
Q1 2025
$-1.66
Q2 2025
$-1.65
Q3 2025
$-1.52
Q4 2025
$-0.48
Q1 2026
Latest RevenueN/A
Latest Net Income-1847706
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q1 2026-$0.48-1847706+89.3%
Q4 2025-$1.52-1861888-107.0%
Q3 2025-$1.65-1691989+91.9%
Q2 2025-$1.66-1701093+96.0%
Q1 2025-$4.47-2303587+93.7%
Q4 2024$21.86-3150938+171.0%
Q3 2024-$20.41-3173156+74.8%
Q2 2024-$41.82-2829106+55.7%
Q1 2024-$70.60-3134262
Q4 2023-$30.80-2133973
Q3 2023-$80.90-1719211
Q2 2023-$94.30-1701364
Dermata Therapeutics (DRMA) — Earnings